NDAVAGINALRING
Approved
Oct 2001
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
5/8 — Partial
NUVARING (etonogestrel and ethinyl estradiol) by Merck & Co. is estrogen receptor agonists [moa]. Approved for pregnancy. First approved in 2001.
Drug data last refreshed 13h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NuvaRing is a vaginal contraceptive ring containing etonogestrel and ethinyl estradiol that works as an estrogen receptor agonist to prevent pregnancy. It is a non-daily hormonal contraceptive indicated for pregnancy prevention in women of reproductive age. The ring is inserted vaginally and provides continuous hormone release over a three-week cycle.
$0.197MPart D
LOE ApproachingLOE approaching with modest Part D utilization (544 claims, $197K annual spending) suggests a mature, niche product requiring strategic repositioning and retention focus.
Mechanism of Action
Estrogen Receptor Agonists
Pharmacologic Class:
Estrogen
Indications (1)
Clinical Trials (1)
NuvaRing Versus Marvelon in the Coordination of In Vitro Fertilization Cycles
Started Jul 2012
7 enrolled
Infertility
Career Relevance
No linked job openings currently identified for NuvaRing, reflecting modest commercial scale ($197K Part D annual spending, 544 claims) and mature product status. Merck teams supporting this product likely focus on market retention, generic defense, and cost management rather than growth initiatives.
Worked on NUVARING at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.